TP53 and Li-Fraumeni syndrome: For example, Li Fraumeni syndrome (LFS) patients with specific p53 DBD mutations (associated with impaired anti-proliferative functions in H1299 cultured cells) have tumour incidences at an earlier age compared to LFS patients harbouring germline TP53 mutations retaining anti-proliferative functions [112].